These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32557294)

  • 1. Use of "Big Data" to Evaluate Responses to Changes in Regulatory Guidelines: Trends in Genotoxicity Testing Packages for New Pharmaceutical Products.
    Reeve L; Baldrick P; Newell A; Templeton S
    Ther Innov Regul Sci; 2020 Jul; 54(4):764-769. PubMed ID: 32557294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Jun; 77(110):33748-9. PubMed ID: 22675782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact.
    Müller L; Kikuchi Y; Probst G; Schechtman L; Shimada H; Sofuni T; Tweats D
    Mutat Res; 1999 May; 436(3):195-225. PubMed ID: 10354523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International regulatory requirements for genotoxicity testing for pharmaceuticals used in human medicine, and their impurities and metabolites.
    Galloway SM
    Environ Mol Mutagen; 2017 Jun; 58(5):296-324. PubMed ID: 28299826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity testing: current practices and strategies used by the pharmaceutical industry.
    Purves D; Harvey C; Tweats D; Lumley CE
    Mutagenesis; 1995 Jul; 10(4):297-312. PubMed ID: 7476265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and data interpretation of the in vivo comet assay in pharmaceutical industry: EFPIA survey results.
    van der Leede BJ; Doherty A; Guérard M; Howe J; O'Donovan M; Plappert-Helbig U; Thybaud V
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Dec; 775-776():81-8. PubMed ID: 25435358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Strategy to Predict Carcinogenicity of Antiparasitics Based on a Combination of DNA Lesions and Bacterial Mutagenicity Tests.
    Liu Q; Lei Z; Zhu F; Ihsan A; Wang X; Yuan Z
    Front Public Health; 2017; 5():288. PubMed ID: 29170735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences with the in vivo and in vitro comet assay in regulatory testing.
    Frötschl R
    Mutagenesis; 2015 Jan; 30(1):51-7. PubMed ID: 25527728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
    Beken S; Kasper P; van der Laan JW
    Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic toxicity assessment: employing the best science for human safety evaluation part IV: a strategy in genotoxicity testing in drug development: some examples.
    Lorge E; Gervais V; Becourt-Lhote N; Maisonneuve C; Delongeas JL; Claude N
    Toxicol Sci; 2007 Jul; 98(1):39-42. PubMed ID: 17369197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of genotoxicity testing of FDA approved large molecule therapeutics.
    Sawant SG; Fielden MR; Black KA
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):87-97. PubMed ID: 24932799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
    Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
    Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of improved QSAR models for predicting the outcome of the in vivo micronucleus genetic toxicity assay.
    Yoo JW; Kruhlak NL; Landry C; Cross KP; Sedykh A; Stavitskaya L
    Regul Toxicol Pharmacol; 2020 Jun; 113():104620. PubMed ID: 32092371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference control data obtained from an in vivo comet-micronucleus combination assay using Sprague Dawley rats.
    Kasamoto S; Masumori S; Tanaka J; Ueda M; Fukumuro M; Nagai M; Yamate J; Hayashi M
    Exp Toxicol Pathol; 2017 Apr; 69(4):187-191. PubMed ID: 28108073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals.
    Brambilla G; Martelli A
    Mutat Res; 2009; 681(2-3):209-229. PubMed ID: 18845271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo comet assay: use and status in genotoxicity testing.
    Brendler-Schwaab S; Hartmann A; Pfuhler S; Speit G
    Mutagenesis; 2005 Jul; 20(4):245-54. PubMed ID: 15899933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to siRNA-GalNAc Conjugates in Systems of the Standard Test Battery for Genotoxicity.
    Janas MM; Jiang Y; Duncan RG; Hayes AN; Liu J; Kasperkovitz PV; Placke ME; Barros SA
    Nucleic Acid Ther; 2016 Dec; 26(6):363-371. PubMed ID: 27387336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxicity guidelines recommended by International Conference of Harmonization (ICH).
    Kamath GH; Rao KS
    Methods Mol Biol; 2013; 1044():431-58. PubMed ID: 23896892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.